#United States #Salt Lake City #medical technology #Averra Holdings #ZIEN Medical

Averra Holdings Announces Partnership with ZIEN Medical

Averra Holdings, LLC, a prominent portfolio company under Banner Capital, has recently entered into a partnership with ZIEN Medical Technologies, a leading player in medical device contract design and manufacturing services based in Salt Lake City. This collaboration, announced on June 16, 2025, promises to expand the capability of both companies while enhancing the service offerings for their clients in the medical device sector.

About ZIEN Medical Technologies

Founded in 2009, ZIEN Medical has established itself as a vertically integrated CDMO (Contract Design and Manufacturing Organization), specializing in a comprehensive suite of services that includes product design development, manufacturing, packaging, sterilization, and quality regulatory support for medical device companies. As part of this partnership, ZIEN will enhance its offerings to include turnkey packaging design and solution services, which are crucial for accelerating product launches in the medtech sector.

Benefits of the Collaboration

The partnership between Averra and ZIEN is poised to deliver significant benefits to their respective clients. According to Ron Labrum, Chairman of Averra, the collaboration aims to not just enhance their market position but to provide a higher level of service and efficiency for clients looking to introduce innovative medical solutions. The joint ventures will allow them to streamline regulatory processes, reduce operational costs, and significantly speed up the time to market for new products.

Labrum emphasized, "ZIEN's unique approach to design and manufacturing makes it an ideal partner, especially for OEMs looking for innovative product strategies both domestically and internationally." This indicates a strong alignment between the two companies' goals and operational methodologies.

Insights from Leadership

Tim Nieman, CEO of ZIEN, expressed enthusiasm about the newfound partnership, stating, "We have built trust and long-standing relationships with our clients over the years. The alliance with Averra and Banner Capital will empower us to upscale our operations while maintaining the high quality defined by our customer base." His remarks underscore ZIEN's dedication to its clients and highlight the operational scalability that this partnership brings.

Averra Packaging's CEO, Jeremy Horton, shared his excitement regarding ZIEN's integration into the Averra family. He noted that the partnership aligns perfectly with Averra's mission to serve the medical device industry comprehensively. The collaboration between Averra and ZIEN is heralded as a unique opportunity that generates value beyond what each organization could achieve individually.

Market Context and Future Prospects

Both Averra and ZIEN are capitalizing on a recent resurgence of interest in domestic manufacturing and a growing demand for integrated services tailored for medtech companies. Experts like Thomas Busby from Outcome Capital highlight that this partnership signals a positive trend for the medical technology sector as it combines assets and expertise to better serve clients in a competitive landscape. The transaction's terms have not been disclosed, but the implications for the medtech community are clearly significant and promising.

As the two entities move forward, their strategic partnership signals a robust commitment to innovation and quality in the medical device landscape, setting the stage for new advancements and improved market efficiencies. This collaboration embodies a trend toward more integrated solutions in the evolving medtech industry, ensuring that both companies can thrive together in a rapidly changing market environment.